Conclusion
When evaluating focal liver disease, a variety of imaging modalities and recent techniques can be used, depending on the patient's history, the clinical suspicion to be addressed, the probability of a certain disease, as well as the availability and the radiologist's personal knowledge of a certain imaging method. Because of these factors, no rigid diagnostic algorithm can be given. Nevertheless, specific contrast agents and tailored dynamic imaging protocols are prerequisites for obtaining optimal results.
Similar content being viewed by others
References
Wernecke K, Rummeny E, Bongartz G et al (1991) Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT and MR imaging. AJR 157:731–739
Ohlsson B, Tranberg KG, Lundstedt C et al (1993) Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. Eur J Surg 159:275–281
Leen E, Angerson WJ, Yarmenitis S et al (2002) Multi-centre clinical study evaluating the efficary of Sono Vue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 41(3):200–206
Albrecht T, Blomley MJK, Burns PN, et al (2003) Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 227:361–370
Liu JB, Merton DA, Goldberg BB, et al (2002) Contrast-enhanced two-and there dimensional sonography for evaluation of intra-abdominal haemorrhage. J Ultrasound Med 21(2):161–169
Ding H, Kudo M, Onda H, et al (2001) Evaluation of post treatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 221(3):721–730
Albrecht T, Hoffmann CW, Wolf KJ (2001) Ultrasound diagnosis of liver metastases with liver specific contrast medial]. Radiologe 41(1):8–15
Semelka RC, Martin DR, Balci C, et al (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13(3):397–401
Oudkerk M, Torres CG, Song B, et al (2002) Characterization of liver lesions with mangafodir trisodium-enhanced MR imaging: multicenter study comparing MR and dualphase spiral CT. Radiology 223(2):517–524
Vogl TJ, Stupavsky A, Pegios W, Hammerstingl R, Mack M, Diebold T, et al (1997) Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation. Radiology 205(3):721–728
Kang BK, Lim JH, Kim SH, et al (2003) Preoperative depiction of hepatocellular carcinoma: Ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology 226:79–85
Liou J, Lee JK, Borrello JA, Brown JJ (1994) Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images. Magn Reson Imaging 12(1):71–79
Vogl TJ, Kummel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200(1):59–67
Muller RD, Vogel K, Neumann K, Hirche H, Barkhausen J, Stoblen F, et al (1998) [MRI with supermagnetic iron particles versus double-spiral CT in identification of malignant liver lesions]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 168(5):436–443
Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ (1999) Hepatic lesion detection: comparison of MR imaging after the administration of super paramagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210(2):459–466
Reimer P, Jahnke N, Fiebich M, Schima W, Deckers F, Marx C, et al (2000) Hepatic lesion detection and characterization: value of nonenhanced MR imaging, super paramagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217(1):152–158
Petersein J, Spinazzi A, Giovagnoni A, et al (2000) Focal lier lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging: a multicenter phase III clinical study. Radiology 215:727–736
Delbeke D, Rose M, Chapman WC, et al (1996) Potimal imterpretation of F-18FDG imaging of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 40:1784–1792
Vitola JV, Delbeke D, Sandler MP, et al (1996) Positron emission tomography to stage metastatic colorectal carcinoma to the liver. Am J Surg 171:21–26
Torizuka T, Tamaki N, Inokuma T, et al (1994) Value of fluorine-18-FDG PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 35:1965–1969
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uggowitzer, M.M. What is the current situation in liver imaging?. Eur Radiol 13 (Suppl 3), N65–N69 (2003). https://doi.org/10.1007/s00330-003-0010-4
Issue Date:
DOI: https://doi.org/10.1007/s00330-003-0010-4